The current pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has triggered an
Broadly cross-reactive antibody to SARS-CoV-2 RBD with robust resistance to mutational escape
What’s the Future of Telehealth? It’s ‘Complicated’
The use of telehealth may have skyrocketed during the COVID-19 pandemic, but it also exposed a digital divide, speaker after
US suicides dropped last year, defying pandemic expectations
The number of U.S. suicides fell nearly 6% last year amid the coronavirus pandemic—the largest annual decline in at least
The GovLab, AFD and Expertise France select 7 projects to address COVID-19 challenges in Africa
Out of a field of over 80 proposals by organizations in Africa — many working in collaboration — The Governance
Lessons of Hunger: Pandemic Prompts Fresh Thinking, New Players in US Food Aid
CHICAGO (Reuters) – On a recent morning in Chicago’s Southwest side, young workers hefted boxes of food into vans for
Match Day 2021: Dermatology Holds Steady
Despite the pandemic, Match Day 2021 was the largest on record, and while the number of dermatology positions offered declined
One in 10 older adults have gotten a ‘pandemic pet,’ poll finds
A lot of the attention around “pandemic pets” has focused on families with children getting a cat, dog or other
Study shows where money is best spent to fight a pandemic
In deciding on how to combat pandemics like COVID-19, the total amount a government is willing to invest is critical.
Why does convalescent plasma therapy for severe COVID-19 show mixed success?
Treatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use
Why does convalescent plasma therapy for severe COVID-19 show mixed success?
Treatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use